{"_links": {"parentPackage": {"href": "/mdr/ct/packages/protocolct-2018-06-29", "title": "PROTOCOL Controlled Terminology Package 34 Effective 2018-06-29", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/protocolct-2018-03-30/codelists/C99076", "title": "CDISC SDTM Intervention Model Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/protocolct/codelists/C99076", "title": "Version-agnostic anchor resource for codelist C99076", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/protocolct-2018-06-29/codelists/C99076", "title": "CDISC SDTM Intervention Model Terminology", "type": "Code List"}}, "conceptId": "C99076", "definition": "A terminology codelist relevant to the trial design developed to compare treatment groups.", "extensible": "true", "name": "Intervention Model Response", "preferredTerm": "CDISC SDTM Intervention Model Terminology", "submissionValue": "INTMODEL", "synonyms": ["Intervention Model Response"], "terms": [{"conceptId": "C82637", "definition": "Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study.", "preferredTerm": "Crossover Study", "submissionValue": "CROSS-OVER"}, {"conceptId": "C82638", "definition": "Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other.", "preferredTerm": "Factorial Study", "submissionValue": "FACTORIAL"}, {"conceptId": "C82639", "definition": "Participants are assigned to one of two or more treatment groups in parallel for the duration of the study.", "preferredTerm": "Parallel Study", "submissionValue": "PARALLEL"}, {"conceptId": "C142568", "definition": "Groups of participants are assigned to receive interventions based on prior milestones being reached in the study. (clinicaltrials.gov)", "preferredTerm": "Group Sequential Design", "submissionValue": "SEQUENTIAL"}, {"conceptId": "C82640", "definition": "All trial participants are assigned to a single treatment group for the duration of the study.", "preferredTerm": "Single Group Study", "submissionValue": "SINGLE GROUP"}]}